# David Weisman, M.D. – FDA Inspection, Sep 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/david-weisman-md/abaf7643-86f4-4fcb-9040-0ff1ad879e37
Source feed: FDA_Inspections

> FDA inspection 1248800 of David Weisman, M.D., September 09, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248800
- Company Name: David Weisman, M.D.
- Inspection Date: 2024-09-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/stephanie-c-mangigian/0cf25e6b-1e5d-4088-a13c-11483e2380ba)

Company: https://www.keypedia.com/companies/david-weisman-md/196171cd-76f2-45dc-b293-6f4d3e4cf44a

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8